0

Journal Articles

in Prostate Cancer
 61-80 of 100 Articles
Original Contribution |  July 06, 2005 FREE
Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower
Ian M. Thompson, MD; Donna Pauler Ankerst, PhD; Chen Chi, MS; et al.
JAMA. 2005;294(1):66-70. doi:10.1001/jama.294.1.66.
Editorial |  May 04, 2005
The Natural History of Clinically Localized Prostate Cancer
Peter H. Gann, MD, ScD; Misop Han, MD
JAMA. 2005;293(17):2149-2151. doi:10.1001/jama.293.17.2149.
Original Contribution |  May 04, 2005 FREE
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Peter C. Albertsen, MD, MS; James A. Hanley, PhD; Judith Fine, BA
JAMA. 2005;293(17):2095-2101. doi:10.1001/jama.293.17.2095.
Commentary |  November 24, 2004
Shared Medical Decision Making:  Problems, Process, Progress
Robert A. McNutt, MD
JAMA. 2004;292(20):2516-2518. doi:10.1001/jama.292.20.2516.
Medical News and Perspectives |  November 17, 2004
Is PSA Testing Still Useful?
JAMA. 2004;292(19):2326-2327. doi:10.1001/jama.292.19.2326.
Editorial |  August 18, 2004
Radiation Therapy and Androgen Suppression as Treatment for Clinically Localized Prostate Cancer:  The New Standard?
Theodore L. DeWeese, MD
JAMA. 2004;292(7):864-866. doi:10.1001/jama.292.7.864.
Original Contribution |  August 18, 2004 FREE
6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate Cancer:  A Randomized Controlled Trial
Anthony V. D'Amico, MD, PhD; Judith Manola, MS; Marian Loffredo, RN, OCN; et al.
JAMA. 2004;292(7):821-827. doi:10.1001/jama.292.7.821.
Editorial |  June 09, 2004
Waiting Time in Prostate Cancer
Alfred I. Neugut, MD, PhD; Victor R. Grann, MD, MPH
JAMA. 2004;291(22):2757-2758. doi:10.1001/jama.291.22.2757.
Original Contribution |  June 09, 2004 FREE
Natural History of Early, Localized Prostate Cancer
Jan-Erik Johansson, MD, PhD; Ove Andrén, MD; Swen-Olof Andersson, MD, PhD; et al.
JAMA. 2004;291(22):2713-2719. doi:10.1001/jama.291.22.2713.
Original Contribution |  April 07, 2004 FREE
Ejaculation Frequency and Subsequent Risk of Prostate Cancer
Michael F. Leitzmann, MD; Elizabeth A. Platz, ScD; Meir J. Stampfer, MD; et al.
JAMA. 2004;291(13):1578-1586. doi:10.1001/jama.291.13.1578.
Editorial |  March 17, 2004
Salvage Radiotherapy for Recurrent Prostate Cancer:  The Earlier the Better
Mitchell S. Anscher, MD
JAMA. 2004;291(11):1380-1382. doi:10.1001/jama.291.11.1380.
Original Contribution |  March 17, 2004 FREE
Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson, MD; Shahrokh F. Shariat, MD; Michael J. Zelefsky, MD; et al.
JAMA. 2004;291(11):1325-1332. doi:10.1001/jama.291.11.1325.
Health Agencies Update |  July 16, 2003
Finasteride Can Reduce Prostate Cancer Risk
JAMA. 2003;290(3):324. doi:10.1001/jama.290.3.324-a.
Original Contribution |  June 19, 2002 FREE
Vasectomy and Risk of Prostate Cancer
Brian Cox, MB, PhD; Mary J. Sneyd, MB, PhD; Charlotte Paul, MB, PhD; et al.
JAMA. 2002;287(23):3110-3115. doi:10.1001/jama.287.23.3110.
Scientific Review and Clinical Applications |  June 19, 2002 FREE
Vitamins for Chronic Disease Prevention in Adults:  Scientific Review
Kathleen M. Fairfield, MD, DrPH; Robert H. Fletcher, MD, MSc
JAMA. 2002;287(23):3116-3126. doi:10.1001/jama.287.23.3116.
Original Contribution |  April 03, 2002 FREE
α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
Mark A. Rubin, MD; Ming Zhou, MD, PhD; Saravana M. Dhanasekaran, PhD; et al.
JAMA. 2002;287(13):1662-1670. doi:10.1001/jama.287.13.1662.
Medical News and Perspectives |  February 27, 2002
Study Concludes That Moderate PSA Levels Are Unrelated to Prostate Cancer Outcomes
JAMA. 2002;287(8):969-970. doi:10.1001/jama.287.8.969.
Medical News and Perspectives |  February 20, 2002
Genome Analysis Yields Mutations Linked to Hereditary Prostate Cancer
JAMA. 2002;287(7):827-828. doi:10.1001/jama.287.7.827.
Medical News and Perspectives |  April 11, 2001
CDC Unveils First Report on Toxins in People
JAMA. 2001;285(14):1827-1828. doi:10.1001/jama.285.14.1827.
Original Contribution |  September 20, 2000 FREE
Comparative Efficiency of Prostate-Specific Antigen Screening Strategies for Prostate Cancer Detection
Kevin S. Ross, MPH; H. Ballentine Carter, MD; Jay D. Pearson, PhD; et al.
JAMA. 2000;284(11):1399-1405. doi:10.1001/jama.284.11.1399.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  Mar 11, 2013
Comparing 3 Techniques for Eliciting Patient Values for Decision Making About Prostate-Specific Antigen Screening:  A Randomized Controlled Trial
Michael Patrick Pignone, MD, MPH; Kirsten Howard, PhD, MPH; Alison Tytell Brenner, MPH; et al.
JAMA Internal Medicine
Invited Commentary  |  Mar 11, 2013
Bridging the Gap at the Center of Patient Centeredness: Individual Patient Preferences in Health Care Decision Making:  Comment on “Comparing 3 Techniques for Eliciting Patient Values for Decision Making About Prostate-Specific Antigen Screening”
Sara J. Knight, PhD
JAMA Internal Medicine
In This Issue of JAMA Internal Medicine  |  Mar 11, 2013
In This Issue of JAMA Internal Medicine
JAMA Internal Medicine
Editor's Correspondence  |  Mar 11, 2013
Prostate-Specific Antigen for Prostate Cancer Screening: A Different Strategy Should Be Planned
Giuseppe Lippi, MD; Camilla Mattiuzzi, MD; Gianfranco Cervellin, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems